Research theme for competitive and other funds (1):
肺癌の外科的治療
Papers (105):
Shinsuke SAISHO, Katsuhiko SHIMIZU, Yuji NOJIMA, Takeshi KUROSAKI, Masao NAKATA. The biological Characteristics of Solid Components are Different between Part-Solid-Type and Solid-Type in Lung Adenocarcinoma. Kawasaki Medical Journal. 2022. 47. 85-97
Saisho S, Nojima Y, Kurosaki T, Shimizu K, Nakata M. Pulmonary Resection of the Primary Tumor for Patients with Stage IV Non-Small-Cell Lung Cancer. Japanese Journal of Cancer Clinics. 2021. 65. 5. 451-457
Norihito Okumura, Junichi Soh, Hiroyuki Suzuki, Masao Nakata, Toshiya Fujiwara, Hiroshige Nakamura, Makoto Sonobe, Takuji Fujinaga, Kazuhiko Kataoka, Kenichi Gemba, et al. Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301. BMC cancer. 2021. 21. 1. 506-506
Okita R, Shimizu K, Nojima Y, Saisho S, Nakata M. Tofacitinib overcomes an IFNγ-induced decrease in NK cell-mediated cytotoxicity via the regulation of immune-related molecules in LC-2/ad. Thoracic Cancer. 2021. 12. 6. 775-782
Nakata M, Nojima Y, Saisho S, Kurosaki T, Shimizu K. Perioperative Therapy for Non-Small Cell Lung Cancer - Current Status and Future Perspective -. Kawasaki Medical Journal. 2020. 46. 59-72